Fawzy A Saad (Ph.D.)
Affiliation: Saad Pharmaceuticals, Tallinn
University / Institution: Saad Pharmaceuticals
Department: Department of Drug Discovery
Designation: Chief Executive Officer
Email: fa_saad@yahoo.co.uk
Country: Estonia
Dr. Fawzy A. Saad is currently the Chief Executive Officer of Saad Pharmaceuticals in Tallinn, Estonia, where he leads innovative biopharmaceutical research focused on gene therapy and precision medicine for rare genetic and age-related disorders. He is a renowned molecular geneticist and biotechnology expert with over 30 years of international experience in genetic research, gene therapy, and orthopaedic molecular biology. He holds a Ph.D. in Human Molecular Genetics from Padua University, Italy, and has conducted pioneering research across esteemed institutions including the University of Toronto, Wake Forest University, Harvard Medical School, and Albert Einstein College of Medicine. His extensive work spans dystrophinopathies, bone remodeling, tendon regeneration, and metabolic bone diseases, resulting in over 45 peer-reviewed publications and multiple patents. Dr. Saad has also served as a scientific advisor and editorial board member for leading journals, mentored numerous researchers, and led training in advanced molecular techniques.